Announce Date | 05/29/2025 |
EPS Normalized Actual | $1.55 (Miss by $-0.15) |
EPS GAAP Actual | $1.55 (Miss by $-0.15) |
Revenue Actual | $23.378B |
Revenue Surprise | Beat by $23378M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Feb 2028 | 9.53 | 12.96 | 9.25469 | 9.9023 | 1 |
Jan 2028 | 9.53 | 12.96 | 9.2573 | 9.90505 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (May 2025) | 1.39 | 1.39 | 23.378B | 100% | 23378M |
FQ1 2025 (Jan 2025) | 2.17 | 2.17 | 23.931B | 100% | 23931M |
FQ4 2024 (Nov 2024) | 1.58 | 1.58 | 24.366B | 100% | 24366M |
FQ3 2024 (Aug 2024) | 0 | 0 | 25.026B | 100% | 25026M |
FQ4 2012 (Nov 2012) | 0.27 | 0.27 | 13.721B | 100% | 13721M |
FQ1 2013 (Feb 2013) | 0.3 | 0.3 | 14.314B | 100% | 14314M |
FQ2 2013 (May 2013) | 0.07 | 0.07 | 14.074B | 100% | 14074M |
FQ3 2013 (Aug 2013) | 0.12 | 0.12 | 14.514B | 100% | 14514M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Feb 2028) | 3.81896 | -- | 3.79291 | 3.87032 | 7 |
FQ4 2027 (Oct 2027) | 2.73725 | -- | 2.71617 | 2.77456 | 8 |
FQ3 2027 (Jul 2027) | 2.14081 | -- | 2.12433 | 2.16999 | 14 |
FQ2 2027 (Apr 2027) | 1.97851 | -- | 1.96328 | 2.00548 | 7 |
FQ1 2027 (Jan 2027) | 3.36868 | -- | 3.26441 | 3.55397 | 4 |
FQ4 2026 (Nov 2026) | 2.30363 | -- | 2.24087 | 2.38809 | 3 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Feb 2028) | 30.05B | -- | 29.89B | 30.36B | 8 |
FQ4 2027 (Oct 2027) | 28.62B | -- | 28.45B | 28.92B | 7 |
FQ3 2027 (Jul 2027) | 27.44B | -- | 27.27B | 27.72B | 7 |
FQ2 2027 (Apr 2027) | 24.91B | -- | 24.77B | 25.18B | 7 |
FQ1 2027 (Jan 2027) | 27.76B | -- | 27.1B | 28.93B | 4 |
FQ4 2026 (Nov 2026) | 25.16B | -- | 24.63B | 25.87B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | 1.39 | 1.39 | 100% | |
FQ1 2025 (Jan 2025) | 2.17 | 2.17 | 100% | |
FQ4 2024 (Nov 2024) | 1.58 | 1.58 | 100% | |
FQ3 2024 (Aug 2024) | 0 | 0 | NAN% | |
FQ4 2012 (Nov 2012) | 0.27 | 0.27 | 100% | |
FQ1 2013 (Feb 2013) | 0.3 | 0.3 | 100% | |
FQ2 2013 (May 2013) | 0.07 | 0.07 | 100% | |
FQ3 2013 (Aug 2013) | 0.12 | 0.12 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (May 2025) | $0B | $23.38B | $23378M | 100% |
FQ1 2025 (Jan 2025) | $0B | $23.93B | $23931M | 100% |
FQ4 2024 (Nov 2024) | $0B | $24.37B | $24366M | 100% |
FQ3 2024 (Aug 2024) | $0B | $25.03B | $25026M | 100% |
FQ4 2012 (Nov 2012) | $0B | $13.72B | $13721M | 100% |
FQ1 2013 (Feb 2013) | $0B | $14.31B | $14314M | 100% |
FQ2 2013 (May 2013) | $0B | $14.07B | $14074M | 100% |
FQ3 2013 (Aug 2013) | $0B | $14.51B | $14514M | 100% |